| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $377.1M | +52.2% |
| Cost of Revenue | $313.2M | +21.9% |
| R&D Expense | $405.3M | +46.8% |
| SG&A Expense | $501.6M | +0.6% |
| Interest Expense | $189.3M | +84.2% |
| Pre-tax Income | -$318.7M | +33.8% |
| Income Tax | $1.7M | -38.9% |
| Net Income | -$320.4M | +33.8% |
| EPS (Basic) | -$0.40 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.42B | +187.4% |
| Total Assets | $19.01B | +107.1% |
| Long-term Debt | $5.49B | +39.0% |
| Total Liabilities | $13.48B | +201.0% |
| Stockholders' Equity | $5.21B | +19.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.26B | -437.4% |
| Investing Cash Flow | -$106.3M | -196.5% |
| Financing Cash Flow | $8.44B | +1132.1% |
| +60.0% |
| EPS (Diluted) | -$0.40 | +60.0% |